Skip to main content

Table 1 Demographics

From: Real life persistence rate with antimuscarinic treatment in patients with idiopathic or neurogenic overactive bladder: a prospective cohort study with solifenacin

Characteristic

Patients included

Age: years

 Mean (S.D.)

61.7 (15.4)

 Range

20.1 – 90.2

Gender: no (%)

 

 Men

70 (57%)

 Women

53 (43%)

Starting dose : no (%)

 10 mg/day

12 (9.8)

 5 mg/day

106 (86.2)

 5 mg/2 days

3 (2.4)

 2.5 mg/2 days

1 (0.8)

 unknown

1 (0.8)

Condition: no (%)

 Idiopathic OAB

83 (67.5)

 Neurogenic OAB

40 (32.5)

  1. S.D. Standard deviation